key: cord-0011737-u6nckham
authors: Lau, Joseph W.Y.
title: Editor's perspectives – April 2020
date: 2020-03-20
journal: Int J Surg
DOI: 10.1016/j.ijsu.2020.03.037
sha: 3310bfcc6a8c395f9b4c067fb878e19a790db559
doc_id: 11737
cord_uid: u6nckham

nan

In the March 2020 Issue of Editor's Perspectives, I started to talk about how Industry Revolution evolved from Industry 1.0 to Industry 4.0. Interestingly, surgery had also evolved through four stages of evolution from Surgery 1.0 to Surgery 4.0 roughly around the same periods of time. Although the time periods for the four stages of the two revolutions are not exactly the same, there are a lot of major developments on which these two revolutions are based.

I briefly mentioned about Industry 1.0 occurred at around 1760 to 1840. With remarkable developments in science at that time, production technology, which previously was powered by muscle of men or animals, was replaced by power provided by steam engines. The steam power increased human productivity many times. Further developments in steam-powered ships, or some years later, steam-powered locomotives brought about further massive changes as people and goods can move greater distances within shorter hours.

Starting around the same time, but ending slightly later (18th -20 century) was the first stage of the evolution of Surgery, Surgery 1.0. Although different authors have considered different surgeons to be the father of surgery [1], most would agree that the father of scientific surgery is John Hunter (1728-1793) [2] . This Scottish anatomist, surgeon and pathologist, was well-known to be "an experimental surgical scientist". With his introduction of science into surgery, surgery gradually evolved to become a subject of science in the 19th century. At around this time, Joseph Lister (1827-1912) advocated the use of carbolic acid as an antiseptic in surgery. As a result of the marked improvement in surgical outcomes, he was dubbed "the father of modern surgery" [3] . Antiseptic surgery gradually evolved into aseptic surgery through the subsequent contributions by many clinicians. Furthermore, pain control during surgery had also developed through the stages of nitrous oxide, ether. chloroform and finally into modern anaesthesia [4] . The availability of blood transfusion through the identification of ABO blood groups, and the preservation of stored blood for transfusion made surgery to become much safer [5] .

Thus, science brought Industry and Surgery to develop into Industry 1.0 and Surgery 1.0, respectively. I shall talk in more details on Industry 2.0 ad Surgery 2.0 in the coming Editor's Perspectives.

In this April 2020 Issue of International Journal of Surgery, there is a very important review article which I recommend to all our readers. This article is entitled "World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)". As COVID-19 has evolved to become a global emergency, this review summarized the current state of knowledge surrounding this virus and it should be of interest to all doctors working in the different fields of medicine.

There are two systematic reviews and meta-analyses. The first article "compared the effectiveness of negative-pressure wound therapy to standard therapy in the prevention of complications after vascular surgery". The study concluded that negative pressure wounds therapy dressings reduced surgical site infection after vascular surgery. The second study, based on 18 studies, compared "weight loss and resolution of comorbidities between laparoscopic sleeve gastrectomy and Roux-en-y gastric bypass" concluded that the two procedures had similar effectiveness in reduction of excessive weight loss and in resolution of type 2 diabetes mellitus. However, patients who underwent the former procedure had fewer postoperative complications and reoperation rates than patients who underwent the latter procedure. On the other hand, the latter procedure was superior in the management of patients with dyslipidemia, hypertension and gastroesophageal reflux disease.

A very good systematic review was conducted on 23 randomized, placebo-controlled studies with 4086 participants to find out the "safety and efficacy of Lactobacillus for preventing necrotizing enterocolitis in preterm infants". The study found significant reduction in the incidences of necrotizing enterocolitis and death, although no significant difference was found in the incidences of sepsis between the Lactobacillus and placebo groups.

There are two comparative studies. The first one is a randomized controlled trial comparing "the safety and efficacy of single endoscopic retrograde cholangiopancreatography plus laparoscopic cholecystectomy versus two-stage ERCP followed by laparoscopic cholecystectomy six-to-eight weeks later". The study found that the former treatment offered the advantages of cost, shorter hospital stay and total anaesthesia time as this treatment prevented the development of recurrent acute cholecystitis which occurred in some patients receiving the latter treatment during the wait for delayed cholecystectomy. The second is a propensity score-matched study on the "Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy". The study found tumor diameters and tumor stage to be independent risk factor of intravesical recurrence in these patients. As these patients had poorer prognosis than those patients without intravesical recurrence, a more active postoperative surveillance and treatment strategies should be adopted for them.

For the studies on case series, there is a study using C-reactive protein and drain amylase to predict clinical relevant pancreatic fistula after pancreaticoduodenectomy, a qualitative study on neo-nervegenesis in 3D dynamic responsive implant for inguinal hernia repair, a retrospective multicenter study on safety to manage mild traumatic brain injuries with minor intracranial hemorrhage in the community, a population-based retrospective study on the cancer-specific survival of low prostate-specific antigen in high-grade prostate cancer, and a nationwide retrospective study on 9224 patients looking at short-term outcomes after appendectomy to see whether it was related to preoperative delay or to time of day of the procedure.

Once again, this issue of International of Surgery is loaded with Invited Commentaries/Commentaries/Letters to the Editor. There are 24 invited commentaries on the various articles, and 2 uninvited articles commenting on 2 articles, which have been published in our Journal.

On the 30 th January 2020, the World Health Organization declared the outbreak of COVID-19 to be a Public Health Emergency of International Concern, all clinicians around the world should join hands to fight this virus. I also appeal to our readers that in the fight against this virus, take adequate steps to protect yourselves. Hopefully with a unified global effort, the impact of this virus on global health and economy can be minimized.

Take good care of yourself in the fight against our common enemy, the novel coronavirus.

the Father of Scientific Surgery, American College of Surgeons

The father of modern surgery

History of general anesthesia -Wikipedia

A brief history of blood transfusion through the years